About Docturnal
Docturnal is a Healthcare company based in Hyderabad (India) founded in 2016 by Arpita Singh. Non-invasive solutions for tuberculosis detection and diagnostics are provided. Docturnal has raised $92.31 thousand across 4 funding rounds from investors including Mumbai Angels, Axilor Ventures and CIE IIITH. Docturnal was last valued at $636.97 thousand in October 2019. Its Indian entity Docturnal Private Limited reported revenue of ₹19.1 Lakh. Docturnal offers products and services including TimBre, Pneumonia Solution, and COPD/Asthma Solution. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include Ibrum Technologies and Swaasa.
Company details
Docturnal was founded in 2016 in Hyderabad, India, and operates in the health technology sector. Non-invasive tools for tuberculosis detection, care screening, and diagnostics are developed, including the TimBre app, which analyzes cough sounds recorded by healthcare providers for real-time assessment. Additional solutions for COPD and asthma identification through acoustic analysis are also offered, focusing on aural components for respiratory conditions.
- Headquarters Hyderabad, India
- Founders Arpita Singh
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website docturnal.com
- Social LinkedIn X Facebook
- Legal Name Docturnal Private Limited
- Date of Incorporation 29 Apr, 2016
- Jurisdiction Secunderabad, Telangana, India
- Annual Revenue₹19.1 Lakh
FY 2023 · +518% YoY
- Net Loss-₹3.8 Lakh
FY 2023 · -20% margin
- EBITDA-₹3.9 Lakh
FY 2023 · -20% margin
- Total Equity Funding$92.31K (USD)
in 4 rounds
- Latest Funding Round$21.59K (USD), Seed
Oct 2019
- InvestorsMumbai Angels
& 14 more
Associated legal entities of Docturnal
Docturnal operates through Docturnal Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Docturnal Private Limited CIN U85190TG2016PTC109301 | Active | 29 Apr 2016 | Secunderabad, Telangana | ₹0.2 Cr | 4 | View details |
Products & Services of Docturnal
Docturnal offers a comprehensive portfolio of products and services, including TimBre, Pneumonia Solution, and COPD/Asthma Solution.
Acoustic-based tool for pulmonary TB detection in 20 seconds
Acoustic system for detecting pneumonia and other ailments
Device for screening chronic respiratory conditions
Funding Insights of Docturnal
Docturnal has successfully raised a total of $92.31K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $21.59 thousand completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $92,308
- Total Rounds 4
- Last Round Seed — $21,591
- Investors Count 15
All 4 funding rounds of Docturnal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $21,591 | Seed | $636,972 | Abhijeet Birewar, Purple Ventures | |
| Sep 2018 | $70,717 | Seed | $603,084 | Axilor Ventures | |
| Aug 2017 | Seed | – | AIRmaker | – | |
| Jan 2017 | Seed | $••••• | CIE IIITH | – |
Last known valuation $636,972 (Oct 2019). 15 investors in total: 5 institutional and 10 angel.
Investors in Docturnal
Docturnal has secured backing from 15 investors, including angel and venture fund investors. Prominent investors backing the company include Mumbai Angels, Axilor Ventures and CIE IIITH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Incubation and management consulting services are provided for start-ups and emerging businesses across various sectors. | 2011 | purpleventures.co.in | Mumbai, India | |
Early-stage venture investments are facilitated by Mumbai Angels network. | 2006 | mumbaiangels.com | Mumbai, India | |
Venture capital firm investing in early-stage startups in technology sectors. | 2014 | axilor.com | Bengaluru, India | |
IoT startups are accelerated by a Singapore government-backed program. | airmaker.sg | Singapore, Singapore | ||
Startups in deep tech and related fields are supported. | 2008 | cie.iiit.ac.in | Hyderabad, India | |
AB Abhijeet Birewar | Angel investor and entrepreneur, focused on tech startups, based in India. | unknown_9e2bc07b4ebf46929 | ||
SC Sandhya Chaudhary | Angel investor focusing on early-stage Indian startups in tech and consumer sectors. | unknown_6c16226b93f4478ab | ||
MA Manoj Aheeray | Angel investor and entrepreneur, focused on tech startups in India. | unknown_d7036862828e4fb99 | ||
SG Sunil Garg | Angel investor, ex-MD at Citi, focused on fintech and tech startups | unknown_6abe14fc8d064a41b | ||
AC Anto Chirayath | unknown_fb89bba42b0e4dcd9 |
Investor details for Docturnal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Docturnal Private Limited (Docturnal)
Docturnal Private Limited is the primary company behind Docturnal. The board of Docturnal Private Limited currently have 4 directors; the longest-serving is Rahul Pathri, appointed in 2016. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rahul Pathri DIN 07489074 | Director | 29 Apr 2016 | 10 yrs 5 mo | Docturnal Private Limited |
| Balakrishna Bagadi DIN 07506268 | Director | 29 Apr 2016 | 10 yrs 5 mo | Docturnal Private Limited |
| Vaishnvi Gutha Reddy DIN 08204477 | Director | 25 Oct 2018 | 7 yrs 11 mo | Docturnal Private Limited |
| Arpita Singh DIN 07785429 | Director | 05 Nov 2019 | 6 yrs 11 mo | Docturnal Private Limited |
People of Docturnal
4 people are tracked at Docturnal (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
| Co-Founder & COO | Leadership | |
| CTO | Leadership | |
| Founder, CEO | Leadership | |
Sasidhar Reddy | Data Scientist | Team |
Complete people profiles for Docturnal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Docturnal
Figures of Docturnal Private Limited, the primary company behind Docturnal, for FY 2023. Revenue was ₹19.1 Lakh (+518% year on year). Net loss was -₹3.8 Lakh (-20% margin). EBITDA was -₹3.9 Lakh (-20% margin). Revenue has grown at a compounded annual rate of -5% over three years and +5% over five years.
- ₹19.1 LakhRevenue · FY 2023 · +518% YoY
- -₹3.8 LakhNet loss · -20% margin
- -₹3.9 LakhEBITDA · -20% margin
- ₹1.2 LakhPaid-up capital
- -5%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Docturnal Private Limited are on its company page.
Detailed financial statements for Docturnal
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Docturnal
3 dated milestones of Docturnal across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Docturnal is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $22K.
Competitors of Docturnal
Docturnal has 2 listed competitors in our database. They include Ibrum Technologies and Swaasa.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ibrum.tech | 2015 | Bengaluru, India | Devices for detecting undiagnosed cardiac and respiratory diseases are developed. | |||
| swaasa.ai | 2017 | Hyderabad, India | Respiratory health diagnosis is enabled by AI-based cough analysis. |
Detailed competitors of Docturnal
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Docturnal
Complete news archive for Docturnal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Docturnal
Docturnal was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Docturnal is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Docturnal is a funded company, having raised a total of $92.31K across 4 funding rounds to date.
The primary company behind Docturnal, Docturnal Private Limited, reported revenue of ₹19.1 Lakh for FY 2023, up 518% year on year.
Docturnal was founded in 2016 in Hyderabad, India, and operates in the health technology sector. Non-invasive tools for tuberculosis detection, care screening, and diagnostics are developed, including the TimBre app, which analyzes cough sounds recorded by healthcare providers for real-time assessment. Additional solutions for COPD and asthma identification through acoustic analysis are also offered, focusing on aural components for respiratory conditions.
Docturnal's top competitors include Ibrum Technologies and Swaasa.
Docturnal offers TimBre, Pneumonia Solution, and COPD/Asthma Solution.
Docturnal has 15 investors. Key investors include Mumbai Angels, Axilor Ventures, CIE IIITH, Purple Ventures, and Abhijeet Birewar.
The valuation of Docturnal is $636.97K as of Oct 2019.
Docturnal operates through Docturnal Private Limited.
The legal entities of Docturnal currently have 4 directors, including Rahul Pathri, Vaishnvi Gutha Reddy, Balakrishna Bagadi and others.